BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25661330)

  • 1. Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles.
    Dixit N; Vaibhav K; Pandey RS; Jain UK; Katare OP; Katyal A; Madan J
    Biomed Pharmacother; 2015 Feb; 69():1-10. PubMed ID: 25661330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
    Zhang G; Liu F; Jia E; Jia L; Zhang Y
    Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
    Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells.
    Saini J; Bansal V; Chandra A; Madan J; Jain UK; Chandra R; Jain SM
    Colloids Surf B Biointerfaces; 2014 Jun; 118():101-10. PubMed ID: 24732397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile.
    Alam N; Khare V; Dubey R; Saneja A; Kushwaha M; Singh G; Sharma N; Chandan B; Gupta PN
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():85-93. PubMed ID: 24656356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid-conjugated iron oxide porous nanorods loaded with doxorubicin for targeted drug delivery.
    Yu P; Xia XM; Wu M; Cui C; Zhang Y; Liu L; Wu B; Wang CX; Zhang LJ; Zhou X; Zhuo RX; Huang SW
    Colloids Surf B Biointerfaces; 2014 Aug; 120():142-51. PubMed ID: 24907583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles.
    Xia Y; Xu T; Zhao M; Hua L; Chen Y; Wang C; Tang Y; Zhu B
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z; Li Y; Kohama K; Oneill B; Bi J
    Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel folate conjugated fluorescent nanoparticles for tumor imaging.
    Hou J; Zhang Q; Li X; Tang Y; Cao MR; Bai F; Shi Q; Yang CH; Kong DL; Bai G
    J Biomed Mater Res A; 2011 Dec; 99(4):684-9. PubMed ID: 21913319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release.
    Chen C; Sun W; Wang X; Wang Y; Wang P
    Mater Sci Eng C Mater Biol Appl; 2018 Apr; 85():88-96. PubMed ID: 29407161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate targeted polymeric 'green' nanotherapy for cancer.
    Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
    Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
    Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-assembled liquid-crystalline folate nanoparticles for in vitro controlled release of doxorubicin.
    Misra R; Mohanty S
    Biomed Pharmacother; 2015 Feb; 69():326-36. PubMed ID: 25661378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-conjugated hybrid SBA-15 particles for targeted anticancer drug delivery.
    Pang J; Zhao L; Zhang L; Li Z; Luan Y
    J Colloid Interface Sci; 2013 Apr; 395():31-9. PubMed ID: 23312579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer.
    Sharma M; Malik R; Verma A; Dwivedi P; Banoth GS; Pandey N; Sarkar J; Mishra PR; Dwivedi AK
    J Biomed Nanotechnol; 2013 Jan; 9(1):96-106. PubMed ID: 23627072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy.
    Luiz MT; Abriata JP; Raspantini GL; Tofani LB; Fumagalli F; de Melo SMG; Emery FDS; Swiech K; Marcato PD; Lee R; Marchetti JM
    Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110038. PubMed ID: 31546359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells.
    Madan J; Pandey RS; Jain UK; Katare OP; Aneja R; Katyal A
    Colloids Surf B Biointerfaces; 2013 Jul; 107():235-44. PubMed ID: 23502046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
    Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.